Lead Product(s): Chondrocytes
Therapeutic Area: Musculoskeletal Product Name: Undisclosed
Highest Development Status: Undisclosed Product Type: Cell and Gene therapy
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement January 06, 2020
Under the agreement, Mundipharma obtains the rights to market and distribute CartiLife® in South Korea.